Literature DB >> 10363588

Efficient production of adeno-associated virus vectors using split-type helper plasmids.

Y Ogasawara1, M Urabe, K Kogure, A Kume, P Colosi, G J Kurtzman, K Ozawa.   

Abstract

Adeno-associated virus (AAV) vectors are potentially useful vehicles for the delivery of therapeutic genes into human cells. To determine the optimal expression pattern of AAV proteins (Rep78, Rep68, Rep52, Rep40, and Cap proteins) for packaging the recombinant AAV genome, helper plasmids were split into two portions. In this study, two sets of split-type helper plasmids were prepared; i.e., 1) a Rep expression plasmid (pRep) and Cap expression plasmid (pCap), and 2) a large Rep expression plasmid (pR78/68) and small Rep plus Cap expression plasmid (pR52/40Cap). When AAV vectors were produced using these sets of split-type helper plasmids at various ratios, the optimal ratio of (large) Rep expression plasmid and Cap expression plasmid was 1 to 9 for both sets. More importantly, the titers were comparable to or even higher than that of a conventional helper plasmid (pIM45) (4.9+/-2.1x10(11) vector particles/10 cm dish for pRep and pCap; 2.9+/-1.6x10(11) vector particles/10 cm dish for pR78/68 and pR52/40Cap; and 1.8+/-0.16x10(11) particles/10 cm dish for pIM45). Western analysis of AAV proteins suggests that the expression of a relatively small amount of large Rep and a large amount of Cap is important for optimal vector production. The present study shows that the AAV helper plasmid can be split without losing the ability to package the recombinant AAV genome, and provides us with valuable basic information for the development of efficient AAV packaging cell lines.

Entities:  

Mesh:

Year:  1999        PMID: 10363588      PMCID: PMC5926094          DOI: 10.1111/j.1349-7006.1999.tb00772.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  30 in total

1.  Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein.

Authors:  D M McCarty; M Christensen; N Muzyczka
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  Role for highly regulated rep gene expression in adeno-associated virus vector production.

Authors:  J Li; R J Samulski; X Xiao
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Epidemiology of adenovirus-associated virus infection in a nursery population.

Authors:  N R Blacklow; M D Hoggan; A Z Kapikian; J B Austin; W P Rowe
Journal:  Am J Epidemiol       Date:  1968-11       Impact factor: 4.897

4.  Nucleotide sequence and organization of the adeno-associated virus 2 genome.

Authors:  A Srivastava; E W Lusby; K I Berns
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

5.  High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors.

Authors:  J A Chiorini; C M Wendtner; E Urcelay; B Safer; M Hallek; R M Kotin
Journal:  Hum Gene Ther       Date:  1995-12       Impact factor: 5.695

6.  A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography.

Authors:  K Tamayose; Y Hirai; T Shimada
Journal:  Hum Gene Ther       Date:  1996-03-01       Impact factor: 5.695

7.  Gene therapy against an experimental glioma using adeno-associated virus vectors.

Authors:  H Okada; K Miyamura; T Itoh; M Hagiwara; T Wakabayashi; M Mizuno; P Colosi; G Kurtzman; J Yoshida
Journal:  Gene Ther       Date:  1996-11       Impact factor: 5.250

8.  Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors.

Authors:  G Podsakoff; K K Wong; S Chatterjee
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

9.  Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization.

Authors:  D S Im; N Muzyczka
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  Cell lines for the production of recombinant adeno-associated virus.

Authors:  K R Clark; F Voulgaropoulou; D M Fraley; P R Johnson
Journal:  Hum Gene Ther       Date:  1995-10       Impact factor: 5.695

View more
  1 in total

1.  Separate control of Rep and Cap expression using mutant and wild-type loxP sequences and improved packaging system for adeno-associated virus vector production.

Authors:  Hiroaki Mizukami; Takashi Okada; Yoji Ogasawara; Takashi Matsushita; Masashi Urabe; Akihiro Kume; Keiya Ozawa
Journal:  Mol Biotechnol       Date:  2004-05       Impact factor: 2.695

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.